azimilide

0 marketed 1 in Phase 3

This page covers all azimilide drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Potassium voltage-gated channel subfamily H member 2, Potassium voltage-gated channel subfamily H member 2, Potassium voltage-gated channel subfamily KQT member 1.

Targets

Potassium voltage-gated channel subfamily H member 2, Potassium voltage-gated channel subfamily H member 2, Potassium voltage-gated channel subfamily KQT member 1

Phase 3 pipeline (1)

Patent intelligence